44 min
Seminar, Hosted by U.S. Food and Drug Administration
FDA Grand Rounds – Advancing Real-World Evidence in FDA Regulatory Decision Making
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Recording
Abstract
Routine clinical data can inform regulatory assessments of medicines. Marie Bradley traces the development of the FDA’s real-world evidence program, using guidance and demonstration projects to explain how the agency evaluates evidence of safety and effectiveness.